Exchange: NASDAQ·Updated 07:30 PM EDT

APMD Apnimed Inc.

$27.45
$0.36
(1.29%)
Today
Closed $27.45
$0.4063
(1.48%)
After Hours
Mkt Cap$1.14B
Vol233,022.00

About APMD

Apnimed, Inc. operates as a clinical-stage company. It engages in the discovery, development, and commercialization of oral therapies for sleep-related breathing diseases. The company was founded by Lawrence G. Miller, Barry Wohl and Luigi Taranto Montemurro in 2017 and is headquartered in Cambridge, MA.
30

Bearish Sentiment

How do you feel about APMD?

Advertisement|Remove ads.